Clinical Trials Browser

Phase 2 × Skin Neoplasms × Axitinib × Clear all

NCT04996823 2025-12-04

Axitinib + Ipilimumab in Advanced Melanoma

Phase 2 Recruiting

Melanoma, Skin Neoplasms

NCT00094107 2012-06-26

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Phase 2 Completed

32 enrolled 9 charts

Melanoma, Skin Neoplasms